Editorial Board Member
Ian Martins, Centre for Alzheimer's Disease Research and Care, School of Medical Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, Australia.
Dr. Ian Martins has been invited to join the Editors of various international journals and has been a reviewer for various journals (approx. 40). He was appointed as the Chief Editor for International Journal of Diabetes Research (2014-2017). He is a BIT Member (BIT Congress. Inc) with an H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). The total citations over the past 27 years of scientific research has accumulated to 2900. ResearchGates analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins name places Dr Martins publication stats RG score higher than 96% of the international researchers and is now a SCIENTIST (ResearchGate). He is now a Scientist for The Science Advisory Board (USA). He has reached the top 3% of Academia.edu. researchers and is a connecting researcher with ORCID. Prevention of over eating by food restriction improves liver lipid metabolism and nature of fat consumed is important to improving health. Contribution to biology is the peripheral sink abeta hypothesis and its relevance to organ suicide, diabetes and Alzheimers disease. Dr Martins has received certificates of recognition at various international conferences, world congress and conventions in relation to anti-aging, health and disease. Keynote addresses at Innovate Pharma 2017, Innovate Neurology 2017, World Diabetes and Endocrinology Summit-2017 and Pharmacology and Ethnopharmacology 2016 has been completed with relevance to the current global epidemic on chronic diseases. Invited 1st Plenary Speaker at the Annual Global Health Conference 2016 with relevance to Nutritional diets accelerate amyloid beta metabolism and prevent the induction of chronic diseases and Alzheimers disease. Photon ebooks (Dr Ian Martins was conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM).
Manager Knowledge Management at RED
Altamas Pasha is a Manager Knowledge Management at RED. He is exceptionally strong on editing and proofing of research reports, manuscripts, modernizing organizational brands, producing powerful print and online publications, and using innovation media. As Knowledge Management specialist and Associate Editor Altamas Pasha possess more than twenty one years? of working experience with national and international development organizations in Bangladesh. Before joining Research and Evaluation Division (RED) of BRAC he worked in the Media and Communication Division of Christian Commission for Development in Bangladesh for seven years He has edited number of books, monographs, research reports and peer reviewed journals.
Rajesh K. Harijan
Albert Einstein College of Medicine (AECOM), New York, USA
Dr. Rajesh Harijan obtained his master degree in biotechnology from Indian Institute of Technology (IIT) Bombay, Mumbai, India in 2009. After that as a predoctoral research assistant, he has been trained in protein crystallography and protein chemistry at Indian institute of science (IISc), Bangalore, India. Dr. Harijan has been graduated as PhD from University of Oulu, Finland in March 2015. During his doctoral training, he established structure-function relationships of several fat metabolizing enzymes including acyl-CoA transferases. Soon after his graduation, Dr. Harijan started as postdoctoral fellow in the Schramm laboratory at Albert Einstein college of Medicine. Currently he is trained in drug design, structural biology and protein dynamics. Dr. Harijan´s research interest is to understand the molecular mechanism of chronic diseases, infectious diseases and cancer.
Albert Einstein College of Medicine, New York
Dr. Riyasat Ali has been working in the Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, USA, since February 2013. Before joining here in the Einstein, he has completed his Ph.D. (immunology and peptide based vaccine design) from the Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India, in January 2013. During his thesis work Riyasat has developed peptide based vaccine against Yersinia pestis. Also, he worked on B and T cell epitope mapping on YscF antigen of Y. pestis. Here in the Einstein, Dr. Ali has been working to understand the pathogenesis of Type 1 Diabetes (T1D) by exploiting the antigenic specificities and biology of the anti-beta cells CD4 and CD8 T lymphocyte pool in mouse models of NOD background. Also, the possibilities of the use of diabetogenic T cell receptors (TCRs) to generate putative humanized mouse model for T1D have been extensively studied. Moreover, possibilities of exploring dendritic cells (DCs) in order to generate antigen/peptide specific tolerance have also been studied. Moreover, he is working on DEC-205 (a receptor on dendritic cells) mediated antigen delivery to induce tolerance in T1D studies. Also, Dr. Ali is using DEC-205 mediated antigen delivery to induce HIV peptide/antigen specific immune response when administered along with suitable adjuvants in mice, and this strategy can be used in a number of other infectious diseases. In addition to the bench work, he is also involved in a variety of other academic activities like presenting research papers and attending scientific conferences, meetings and symposia; and also reviewing research papers for a variety of scientific journals of interest. Also, Riyasat is actively involved in making scientific collaborations to understand subject in depth. Moreover, he has trained couple of trainees that gave him a good understanding of subject and also helped him to think critically while designing his experiments and analyzing data. Other than that he is also involved in nonacademic and managerial work as he is an active member of Einstein Senate Council and Einstein Postdoctoral Association, which help him to understand people around in scientific and nonscientific arena and also Einstein administrative functioning.
Resident in Neurology, School of Neurology, University of Catania, Italy
I was born in Catania (Italy) in 1982. I am currently Consultant Neurologist and Clinical Researcher at the Department of Neurology I.C. of the Oasi Institute for Research on Mental Retardation and Brain Aging (I.R.C.C.S.) in Troina (Italy), which is a Collaborating Center of the World Health Organization (WHO) for Research and Training in Neuroscience. After graduation with honours in Medicine in 2007, I trained at the School of Neurology of the University of Catania, and got the international PhD in Basic and Applied Biomedical Sciences at the same Institution. I specialized in cerebrovascular diseases and Neurosonology at the Stroke Unit based on the Sant Andrea Civic Hospital in La Spezia (Italy). As visiting clinical research Fellow, I further trained at the Department of Clinical Neurophysiology of the Royal Victoria Infirmary and at the Department of Neuroscience, Newcastle University (Newcastle-upon-Tyne, UK). In 2013 I was selected for one the six Scientific Fellowship promoted by the European Federation of Neurological Societies (EFNS), with a project titled Visual hallucinations in dementia with Lewy bodies: a combined TMS/EEG study. From October 2015, I teach Neurology as Assistant Professor at the Kore University of Enna (Italy). I have co-authored more than 70 publications in international refereed Journals and Conferences and I also serve as Editorial Board member and invited Reviewer of several international Journals. My main clinical interests are: cerebrovascular diseases, vascular-related cognitive impairments, neuropsychiatric diseases, Clinical Neurophysiology, Transcranial Magnetic Stimulation (TMS) and, more recently, sleep disorders and gluten-related neuropathology. My current scientific activity focuses on the neurophysiological evaluation of cognitive and moodbehavioural characteristics of different neurological and psychiatric diseases. In the last years, our research group has applied electrophysiological investigations and techniques of non-invasive brain stimulation in different clinical contexts, such as cerebrovascular diseases, cognitive impairment, sleep disorders and major depression. In particular, the study of cortical excitability to TMS revealed further insights into the pathophysiological mechanisms and neurochemical basis underlying these conditions. This activity is reflected in scientific publications in international peerreviewed indexed journals and by communications and poster presentations in national and international Meetings. More recently, I am carrying forward investigations based on integration of different neurophysiological methods (TMS-EEG) for the experimental study of the processes underlying neurotransmission and cortical plasticity specifically involved in the regulation of sleep and cognitive functions in both normal and pathological conditions.
Frank N.M. Twisk
ME-de-patiënten Foundation, Zonnedauw 15,1906 HB Limmen, The Netherlands
Director, Medical and Surgical Department of Clinical and Experimental Internist, Second University of Naples, Italy
Doctor Giuseppina Brancaccio was born in Naples the 12/02/1978. Graduated in Medicine and Surgery, in 2004 with a degree discussion on chronic hepatitis Delta,dignity of press, at the Second University of Naples. Qualified to the professional exercise in the session of 2005 at the University of Naples.Winner of competition for the admission to the School of Specialization in Infectious Diseases at the Second University of Naples from the year 2005/2006. Specialized in Infectious Diseases in April, 24, 2010. From October 1to date Research fellow at to Internal and Specialist Medicine. From March,1, 2010 to date PhD fellow in Pharmacology Sciences and Clinical Medicine and Experimental Medicine. On October,1, 2010 she was appointed cultore della materia in Infectious Diseases by the Faculty of Medicine, Second University of Naples.
Stephen L. Nelson
Director, Pediatric Neurology, Tulane-Lakeside Hospital, USA
Dr. Nelson joined the faculty at Tulane University School of Medicine in New Orleans, LA full-time in 2014 as Associate Professor of Pediatrics, Neurology, Neurosurgery and Psychiatry, although he has worked part-time doing Pediatric Neurology since 2007. He is board-certified in both Pediatrics and Child Neurology. He is the Director of Pediatric Neurology and Neurodiagnostics, and performs both inpatient and outpatient evaluations, in addition to reading of EEGs. Dr. Nelson completed his PhD in Biomedical Sciences at University of California, Riverside followed by in his MD at University of California, San Diego. He then completed his Pediatric residency at Wilford Hall Medical Center in San Antonio, Texas and then his Child Neurology residency at Stanford. He served on active duty in the US Air Force from 2000-2013, most recently at Walter Reed and Uniformed Services University of the Health Sciences in Bethesda, MD, where he was the Program Director for the Child Neurology Fellowship, and the Director of Child Neurology for the medical school.
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Hiba Jawdat Barqawi
University of Sharjah, College of Medicine, United Arab Emirates.
Hiba Jawdat Barqawi responsible for coordinating a number of courses which she sees through from the pre-implementation stage to the end. She also supervises numerous undergraduate student projects, many of which have won awards in national as well as international competitions. In addition, she is a member of many of the college committees and is also the Editor of the College of Medicine Newsletter
Tamer M. Shousha
College of Health Sciences, University of Sharjah, Sharjah, UAE
Kausar Sadia Fakhruddin
College of Dental Medicine, University of Sharjah, United Arab Emirates.
Mehmet Mete Altintas
Associate Professor, Rush University, Chicago, USA
Mehmet M. Altintas graduated from Bogazici University, Turkey, and obtained his Ph.D. in Biochemical Engineering in 2001, where he contributed to the development of flux-based analyses of metabolic networks using the tools of fermentation and metabolic engineering. His studies eventually brought him to the United States, where worked as part of an integrated team at the University of Colorado with collaborators at the National Renewable Energy Laboratory (NREL). After joining Dr. Jochen Reisers group at Massachusetts General Hospital in 2004, his interest turned to kidney podocytes. Since then, his main research has concerned the identification of molecular targets involved in the structural changes in glomerulus leading to the development of proteinuria. In 2008, he joined the Department of Hypertension and Nephrology at the University of Miami, as a Research Assistant Professor. Four years later, he was recruited as an Associate Professor by Rush University and still holds the same position. He has more than 35 publications including books, editorial, research paper and review articles.
Burton M. Altura
Professor, Suny Downstate Medical Center, USA
Dr. Burton M. Altura is currently working as a Professor of Physiology, Pharmacology & Medicine State University of New York Downstate Medical Center. He completed his PhD from Newyork University School of Medicine. He published many articles. Dr. Burton M. Altura studies address the two most important issues in vascular biology today: stroke mechanisms; and irreversible cellular destruction in the cardiovascular system caused by alcohol and substance abuse. These studies have already led to the prevention of atherosclerotic lesions, hypertension and stroke-like events in experimental animal models.
University of Texas Medical Branch, Texas, USA
Faculty of Medicine, Nicolaus Copernicus University, Poland
Professor, Department of Medical Research, Hebei Medical University, China
Dr. Bulang Gao is currently working as a Professor in the Department of Medical Research at Hebei Medical University, China. He is also working as visiting professor in the Department of Radiology at Shanghai Jiaotong University Renji Hospital. He completed his Postdoctoral studies in Neurosurgery Department at Tufts Medical Center, USA. His research interest includes Interventional treatment of vascular diseases including cerebral aneurysms, animal experiments for medical research, computational fluid dynamics analysis, and medical statistics analysis and computer skills. He is serving as Editorial Board member and as reviewer for many peer reviewed journals. He has more than 90 publications including books, research paper and review articles.
Neurology Department, Federal Fluminense University, Brazil
Dr. Marco Orsini is currently working as a Neurologist in Neurology Department, Federal Fluminense University, Brazil. He completed his Post-doctorate in neurology and psychiatry from Federal University of Rio de Janeiro and Doctorate in Neurology from Federal University of Rio de Janeiro. His research interest includes Anterior Horn Diseases, Neuromuscular Diseases and Neurorehabilitation. He is also a part of editorial Board member in many journals. He has publications including research paper and review articles.